Marsh & McLennan, US5717481023

Marsh & McLennan stock (US5717481023): Recent trading activity and market position

13.05.2026 - 12:10:47 | ad-hoc-news.de

Marsh & McLennan shares showed a 0.25% gain in recent trading, amid a 52-week range of 161.06 to 235.78 USD. The company offers a 2.2% dividend yield, drawing interest from US investors in insurance and consulting.

Marsh & McLennan, US5717481023
Marsh & McLennan, US5717481023

Marsh & McLennan, a leader in insurance brokerage and risk management, recently saw its stock rise 0.25% to close between 212.63 and 215.24 USD, according to Investing.com as of recent data. Over the past year, the NYSE-listed MRSH has declined 26.97%, reflecting broader market pressures in financial services. The firm maintains a dividend of $3.60 per share, yielding 2.2%, which supports income-focused portfolios.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: Marsh & McLennan Companies, Inc.
  • Sector/industry: Insurance brokerage and consulting
  • Headquarters/country: United States
  • Core markets: Global, with strong US presence
  • Key revenue drivers: Risk management, reinsurance, consulting
  • Home exchange/listing venue: NYSE (MRSH)
  • Trading currency: USD

Official source

For first-hand information on Marsh & McLennan, visit the company’s official website.

Go to the official website

Marsh & McLennan: core business model

Marsh & McLennan operates through subsidiaries like Marsh, Guy Carpenter, Mercer, and Oliver Wyman, providing insurance brokerage, reinsurance, talent and health solutions, and management consulting. The company advises clients in over 130 countries, focusing on risk, strategy, and people risks. Its model emphasizes long-term client relationships and data-driven insights, generating revenue primarily from fees and commissions.

This diversified structure allows Marsh & McLennan to serve corporations, governments, and institutions globally, with a significant footprint in the US market where it supports businesses navigating complex regulatory environments.

Main revenue and product drivers for Marsh & McLennan

Key revenue comes from Marsh's insurance brokerage services, which placed coverage for risks including property, casualty, and cyber threats. Guy Carpenter drives reinsurance placements, while Mercer focuses on retirement, health, and investment consulting. Oliver Wyman contributes through strategy consulting. In the US, these services are critical for Fortune 500 companies managing supply chain and liability exposures.

The firm's emphasis on analytics and technology enhances product offerings, such as risk modeling tools, appealing to US investors seeking exposure to resilient financial services amid economic uncertainty.

Industry trends and competitive position

The insurance brokerage sector faces rising demand for cyber and climate risk solutions, where Marsh & McLennan holds a leading position against peers like Aon. Competitors such as Aon pay out lower dividend percentages from earnings (16.4%), per MarketBeat data. Marsh & McLennan's global scale and US-centric operations position it well in a market projected to grow with increasing regulatory scrutiny.

Why Marsh & McLennan matters for US investors

Listed on the NYSE, Marsh & McLennan provides US investors direct exposure to the $100 billion+ US insurance brokerage market. Its services underpin American businesses' risk management, tying performance to economic cycles and corporate spending on consulting, making it relevant for portfolios tracking S&P 500 financials.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Conclusion

Marsh & McLennan continues to demonstrate stability in insurance and consulting, with recent modest gains and a solid dividend profile amid yearly declines. Its core operations remain vital for global risk management, particularly in the US. Investors monitor trading volumes and sector trends for ongoing developments.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis Marsh & McLennan Aktien ein!

<b>So schätzen die Börsenprofis  Marsh &amp; McLennan Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US5717481023 | MARSH & MCLENNAN | boerse | 69322285 | bgmi